Open access target validation is a more efficient way to accelerate drug discovery
about
Accelerating target discovery using pre-competitive open science-patients need faster innovation more than anyone elseAn open source pharma roadmapOpen Access Could Transform Drug Discovery: A Case Study of JQ1.Establishing a reliable framework for harnessing the creative power of the scientific crowdDonated chemical probes for open science.Changing Trends in Computational Drug Repositioning.
P2860
Open access target validation is a more efficient way to accelerate drug discovery
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Open access target validation is a more efficient way to accelerate drug discovery
@ast
Open access target validation is a more efficient way to accelerate drug discovery
@en
Open access target validation is a more efficient way to accelerate drug discovery
@nl
type
label
Open access target validation is a more efficient way to accelerate drug discovery
@ast
Open access target validation is a more efficient way to accelerate drug discovery
@en
Open access target validation is a more efficient way to accelerate drug discovery
@nl
prefLabel
Open access target validation is a more efficient way to accelerate drug discovery
@ast
Open access target validation is a more efficient way to accelerate drug discovery
@en
Open access target validation is a more efficient way to accelerate drug discovery
@nl
P2860
P3181
P1433
P1476
Open access target validation is a more efficient way to accelerate drug discovery
@en
P2093
Wen Hwa Lee
P2860
P304
P3181
P356
10.1371/JOURNAL.PBIO.1002164
P407
P50
P577
2015-06-01T00:00:00Z